Drug intelligence / Profile preview

tranexamic acid + sucralfate

Development stage
Unknown
Lead developer
National Cheng-Kung University Hospital
Modality
Small Molecules
Administration
Topical
01

Overview

Tranexamic acid + sucralfate is an investigational combination of two small-molecule drugs administered as a topical powder spray via endoscopy for the treatment of gastrointestinal bleeding. Developed by National Cheng Kung University Hospital, the combination leverages the antifibrinolytic properties of tranexamic acid, which inhibits fibrin degradation by binding to tissue plasminogen, and the mucosal protective properties of sucralfate, which forms a physical barrier over wound surfaces. This dual-action approach is intended to stabilize blood clots and protect the bleeding site from further irritation or degradation. Clinical evidence from pilot studies indicates that the combination significantly reduces rebleeding rates in patients with lower gastrointestinal bleeding when applied following standard endoscopic hemostasis.

Other names
Tranexamic acid and sucralfate powder spray
02

Targets

PLG (Plasminogen)PLAU (uPA)

Beyond the preview

Go deeper on tranexamic acid + sucralfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tranexamic acid + sucralfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call